Based on the last webinar.
IMU is well and truly in the initial phases and far from any Big Parma deals. This is the sad reality.
Imugene 2.0 (as they branded it), is basically a cunning way to say, previous platforms failed and we are buying new assets to have another crack.
To date, we haven’t had blockbuster results that will entice Big Pharma to make an offer.
The brutal reality is, we are now years away and we are burning cash.
they need to pull a rabbit out of the hat.
just pray the bile duct study yields promising early results.
Why IMU is a multi multi bagger, page-26417
-
- There are more pages in this discussion • 605 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3429444 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 149299 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |